alexa Comparative Evaluation of Biomed InTray<sup>and#174;</sup>and#160;Colorex MRSA with BD ESwaband#160;Collection Kit/ BBLand#8482; CHROMagar<sup>and#174;</sup>and#160;MRSA II| Abstract
ISSN: 2161-0703

Journal of Medical Microbiology & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
  • Research Article   
  • J Med Microb Diagn 2018, Vol 7(1): 273
  • DOI: 10.4172/2161-0703.1000273

Comparative Evaluation of Biomed InTray® Colorex MRSA with BD ESwab Collection Kit/ BBL™ CHROMagar® MRSA II

Kiran H Bijlani, Marcela Gomez, Rowena Matias, Ana Najafi, Ron Najafi and Sridhar Arumugam*
Emery Pharma Cell Biology and Microbiology, , CA, USA
*Corresponding Author : Sridhar Arumugam, Director of Cell and Microbiology, Emery Pharma Cell Biology and Microbiology, 1000 Altantic Avenue Suite 110 Alameda, CA 94501, USA, Tel: 0015108998828, Email: [email protected]

Received Date: Feb 08, 2018 / Accepted Date: Feb 15, 2018 / Published Date: Feb 19, 2018

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most dangerous antibiotic resistant pathogens and a common cause of most health-care acquired infections. MRSA causes skin, wound and bloodstream infections that can cause sepsis and ultimately lead to death. CDC and WHO have listed MRSA as a serious threat infection and included in The National Action Plan for Combating Antibiotic-resistant Bacteria. Early, reliable, and accurate diagnosis of MRSA in a clinical setting is critical for the treatment and control of infection in hospitals and the community. We comparatively evaluated the efficacy of two commercial diagnostic systems, Biomed InTray® Colorex and BDTM ESwab Regular Collection Kit/ BBL™ CHROMagar® (ESwab + CHROMagar®) to recover 51 MRSA clinical isolates. The percentage recovery of MRSA clinical isolates in InTray® and in ESwab + CHROMagar® was 99% and 75%, respectively. Our findings suggest that InTray® was more efficient than ESwab + CHROMagar® in recovering MRSA clinical isolates.

Keywords: Methicillin-resistant S. aureus (MRSA); Diagnostic test; InTray®; Eswab+CHROMagar®

Citation: Bijlani KH, Gomez M, Matias R, Najafi A, Najafi R, et al. (2018) Comparative Evaluation of Biomed InTray® Colorex MRSA with BD ESwab Collection Kit/ BBL™ CHROMagar® MRSA II. J Med Microb Diagn 7: 273. Doi: 10.4172/2161-0703.1000273

Copyright: © 2018 Bijlani KH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Leave Your Message 24x7
Top